Late-Breaking Peanut Patch Phase IIb Trial Results Unveiled at AAAAI Annual Meeting

Late-Breaking Peanut Patch Phase IIb Trial Results Unveiled at AAAAI Annual Meeting
Houston, TX (PRWEB) February 22, 2015 A team of researchers unveiled the results of their highly anticipated multi-national, double-blind, placebo controlled randomized Phase IIb trial for a peanut patch, known as Viaskin® Peanut. “This is exciting news for families who suffer with peanut allergies because Viaskin represents a new treatment option for patients and ...